Table 4.
Measurements of AT, FIB, F VIII and vWF
| Groups | AT: A (%) | FIB (mg/dl) | vWF: Ag (%) | F VIII: C (%) |
|---|---|---|---|---|
| Control | 123.10 ± 3.281* | 134.730 ± 6.4790* | 48.890 ± 2.4978* | 116.350 ± 3.8254* |
| IH | 117.10 ± 2.885* | 153.120 ± 6.8579* | 57.520 ± 2.3569* | 198.680 ± 7.9140* |
| Emphysema | 105.37 ± 5.779* | 175.790 ± 7.8053* | 65.310 ± 2.3695* | 231.030 ± 13.5187* |
| Overlap | 96.12 ± 5.351* | 201.330 ± 6.6291* | 72.570 ± 3.8268* | 315.920 ± 26.1305* |
| F | 71.570 | 171.073 | 129.446 | 289.047 |
| P | 0.000 | 0.000 | 0.000 | 0.000 |
AT: antithrombin; FIB: fibrinogen; FVIII: Factor VIII; vWF: von Willebrand factor.
*
There is statistical difference significantly compared with other groups.